+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A survey of prescribing habits for high-estrogen oral contraceptives

A survey of prescribing habits for high-estrogen oral contraceptives

Contraception 38(5): 561-565

A simple survey was made of health-care providers in the US to determine their attitudes toward oral contraceptives containing 50 mcg of estrogen. 3 groups were surveyed by mail: 100 gynecologists (2 from each state) chosen from the Directory of Fellows of the American College of Obstetricians and Gynecologists, 100 family practitioners selected from the American Academy of Family Physicians Membership Directory, and 81 members of the Association of Reproductive Health Professionals (50 gynecologists, 25 family practitioners, 6 nurse practitioners). It was found that about 2/3 (61%) of respondents prescribe this group of medication, although few do so regularly. Their use seemed correlated with providers 50 years of age or older. Even members of the association of professionals interested in contraception frequently used these pills (very few members were under 40 years of age). Although this group of contraceptives is being phased out, it is felt that professionals should have ceased their use long ago due to their high risk compared to low-estogen pills. Even though a majority of practitioners precribe high-estrogen pills, very few feel that they are essential. However, 10% responded that it would be a problem if all of these products were taken off the market.

(PDF emailed within 0-6 h: $19.90)

Accession: 039127539

Download citation: RISBibTeXText

PMID: 3197420

DOI: 10.1016/0010-7824(88)90159-x

Related references

The Australian general practice morbidity and prescribing survey, 1969 to 1974. 6. Prescribing: oral contraceptives. Medical Journal of Australia 2(1 Suppl): 27-27, 1976

Attitudes, knowledge and prescribing habits of Brazilian gynecologists regarding extended-cycle oral contraceptives. Gynecological Endocrinology 29(12): 1071-1074, 2014

Extended-use oral contraceptives and medically induced amenorrhea: attitudes, knowledge and prescribing habits of physicians. Contraception 84(4): 384-389, 2012

Oral contraceptives and thrombo embolic disease part 2 estrogen content of oral contraceptives. Journal of the American Medical Association 219(5): 593-596, 1972

Estrogen containing oral contraceptives and serum lipo proteins results from a health screen survey. Proceedings of the University of Otago Medical School 54(3): 83-84, 1976

Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Contraception 74(4): 290-292, 2006

Low vs high estrogen oral contraceptives and ovarian cyst risk. American Journal of Epidemiology 132(4): 768, 1990

Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives. JAMA 219(5): 593-596, 1972

Withdrawal of high estrogen containing oral contraceptives and the demand for medical service. Ugeskrift for Laeger 137(13): 759-762, 1975

The persistence of prescribing habits: a survey and follow-up of prescribing to chronic hospital in-patients. British Journal of Psychiatry 150: 88-91, 1987

The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen. Task Force on Oral Contraceptives. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 40(2): 147-156, 1989

High dose estrogen progestogen oral contraceptives a risk factor for aneurysmal subarachnoid hemorrhage?. Acta Neurologica Scandinavica 76(1): 37-45, 1987

High estrogen dose oral contraceptives in women using anti-epileptic drugs may not protect against pregnancy. Journal of Investigative Medicine 43(SUPPL 1): 95A, 1995

Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives. Bmj 320(7226): 57-58, 2000